Over 90 percent of people with Huntington’s disease develop chorea. Learn about FDA-approved VMAT2 inhibitors, off-label medications, and lifestyle strategies to manage involuntary movements.

Learn about dyskinesia, including its causes, symptoms, types, and available treatment options to help manage involuntary ...

Learn how Huntington’s disease affects mood, including depression, anxiety, apathy, and irritability, plus treatment options and strategies for symptom management.

Ingrezza (valbenazine) is a medication used to treat tardive dyskinesia (TD) and chorea associated with Huntington’s disease. These conditions cause involuntary movements like twitching, jerking, or ...

Neurocrine Biosciences, Inc.  today announced the presentation of new data from a clinician survey highlighting the functional impact experienced by patients with mild tardive dyskinesia (TD) severity ...

Research published in The Journal of Clinical Psychiatry characterizes patient-reported improvement with INGREZZA® (valbenazine) capsules across the KINECT® clinical ...

New analysis from the IMPACT-TD Registry confirms tardive dyskinesia (TD) causes a significant burden for most individuals with concomitant mood ...

Cranial movement disorders are a common neurological problem. These disorders can be limited to the cranial muscles alone or manifest as part of a more generalized movement disorder. Cranial movement ...

New analysis from the IMPACT-TD Registry confirms tardive dyskinesia (TD) causes a significant burden for most individuals with concomitant mood disorders, impacting their lives regardless of ageThe d ...

Regular HDBuzz readers may recall our September 2024 article examining the long history of pridopidine in Huntington’s ...

Symptoms of hantavirus begin with flu-like characteristics such as fever, muscle aches, and fatigue. As the disease progresses, fluid can build up in the lungs, causing breathing difficulties. The ...